|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����Y |
|
���� |
| ��������������� | |
|
��۾� |
|
����Ԫ |
| PubMed | |
|
Article by |
|
Article by |
����Y�������ص��о���չ
��۾�, ����Ԫ
�Ͼ�ҽ�ƴ�ѧ��һ����ҽԺƤ���� �Ͼ� 210029
���粡����,������ز����˰���ķ������о����ְ��综��Ƥ������ѪҺ������Yˮƽ������������Ϊ��,����Y��Ϊһ����Ҫ�����ʿ���ͨ���������-����-Ƥ��ϵͳ�����˰���ķ�����������Y�ķ�������ѧ���ԡ�����緢���Ĺ�ϵ�Լ������������Ļ�����һ������
[2] Balasubramaniam A.Clinical potentials of neuropeptide Y family of hormones.Am J Surg,2002,183(4):430-434.
[3] Galas L,Tonon MC,Beaujean D,et al.Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone(alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.Endocrinology,2002,143(5):1686-1694.
[4] Al'Abadie MS,Senior HJ,Bleehen SS,et al.Neuropeptide and neuronal marker studies in vitiligo.Br J Dermatol,1994,131(2):160.
[5] Liu PY,Bondesson L,Lontz W,et al.The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris:a case-control study.Arch Dermatol Res,1996,288(11):670-675.
[6] Lazarova R,Hristakieva E,Lazarov N,et al.Vitiligo-related neuropeptides in nerve fibers of the skin.Arch Physiol Biochem,2000,108(3):262-267.
[7] Hristakieva E,Lazarova R,Lazarov N,et al.Markers for vitiligo related neuropeptides in human skin nerve fibers.Acta Med Croatica,2000,54(2):53-57.
[8] Tu C,Zhao D,Lin X.Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo.J Dermatol Sci,2001,27(3):178-182.
[9] Lazarova R,Hristakieva E,Lazarov N,et al.Vitiligo-related neuropeptides in nerve fibers of the skin.Arch Physiol Biochem,2000,108(3):262-267.
[10] Misery L.Skin,immunity and the nervous system.Br J Dermatol,1997,137(6):843-850.
[11] Friedman EM,Irwin MR.Modulation of immune cell function by the autonomic nervous system.Pharmacol Ther,1997,74(1):27-38.
[12] Levite M.Neuropeptides,by direct interaction with T cells,induce cytokine secretion and break the commitment to a distinct T helper phenotype.Proc Natl Acad Sci U S A,1998,95(21):12544.
[13] Abdel-Naser MB,Kruger-Krasagakes S,Krasagakis K,et al.Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.Pigment Cell Res,1994,7(1):1-8.
[14] Tu CX,Fu HW,Lin XR.Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.J Dermatol Sci,1999,21(1):59-62.
[15] Al'Abadie MS,Warren MA,Bleehen SS,et al.Morphologic observations on the dermal nerves in vitiligo:an ultrastructural study.Int J Dermatol,1995,34(12):837-840.
[16] Hara M,Toyoda M,Yaar M,et al.Innervation of melanocytes in human skin.J Exp Med,1996,184(4):1385-1395.
[17] Hernanz A,Tato E,De la Fuente M,et al.Differential effects of gastrin-releasing peptide,neuropeptide Y,somatostatin and vasoactive intestinal peptide on interleukin-1 beta,interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects.J Neuroimmunol,1996,71(1-2):25-30.
[18] Krasagakis K,Garbe C,Eberle J,et al.Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.Arch Dermatol Res,1995,287(3-4):259-265.
[19] Tsatmali M,Ancans J,Thody AJ.Melanocyte function and its control by melanocortin peptides.J Histochem Cytochem,2002,50(2):125.
[20] Galas L,Tonon MC,Beaujean D,et al.Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone(alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.Endocrinology,2002,143(5):1686-1694.